Abiopharma

Bone Biologics Announces Pricing of $5.0 Million Public Offering

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

Eastman Chemical Company - Eastman Board Appoints New Director

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA

Helius Medical Technologies Announces Reverse Stock Split

Results of Annual General Meeting

Neurocrine Biosciences Presents New Post-Hoc Data Analyses from KINECT®-HD Study Demonstrating Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntingtons Disease Chorea

Ontrak Health Announces Pricing of $4 Million Public Offering